HRTX Financing Cash Flow
Heron Therapeutics Inc · Financing Cash Flow
HRTX Financing Cash Flow
Latest reported$13.61Mperiod ending
HRTX TTM Cash from Financing ($2.20M → $13.61M)
TTM financing cash flow
High-resolution chart · PNG
HRTX financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 13,613,000 | |
| 14,312,000 | |
| 14,427,000 | |
| 14,631,000 | |
| 1,282,000 | |
| 993,000 | |
| 940,000 | |
| 716,000 | |
| 54,499,000 | |
| 54,326,000 | |
| 54,107,000 | |
| 54,347,000 | |
| 75,492,000 | |
| 75,488,000 | |
| 75,059,000 | |
| 75,107,000 | |
| 94,000 | |
| 154,508,000 | |
| 156,028,000 | |
| 161,303,000 | |
| 161,898,000 | |
| 9,481,000 | |
| 9,105,000 | |
| 168,469,000 | |
| 171,859,000 | |
| 180,393,000 | |
| 186,425,000 | |
| 24,360,000 | |
| 577,000 | |
| 360,150,000 | |
| 357,608,000 | |
| 501,119,000 | |
| 526,166,000 | |
| 132,131,000 | |
| 293,731,000 | |
| 148,643,000 | |
| 194,430,000 | |
| 220,522,000 | |
| 57,455,000 | |
| 57,730,000 | |
| 8,368,000 | |
| 137,643,000 | |
| 137,991,000 | |
| 136,573,000 | |
| 135,488,000 | |
| 64,028,000 | |
| 62,108,000 | |
| 121,251,000 | |
| 121,812,000 | |
| 61,575,000 | |
| 61,229,000 | |
| 1,754,000 | |
| 51,166,000 | |
| 51,112,000 | |
| 50,500,000 | |
| 50,308,000 | |
| 2,289,000 | |
| 24,099,000 | |
| 24,099,000 | |
| 24,299,000 | |
| 21,827,000 | |
| 35,000 | |
| 77,000 | |
| 8,044,000 | |
| 8,049,000 | |
| 8,058,000 | |
| 8,013,000 | |
| 54,000 | |
| 76,000 | |
| 78,000 | |
| 81,000 | |
| 76,000 | |
| -303,000 | |
| 37,256,000 | |
| 37,256,000 | |
| 37,270,000 | |
| 37,629,000 | |
| 76,000 | |
| 79,000 | |
| 88,000 | |
| 82,000 | |
| 110,000 | |
| 119,000 | |
| 135,000 | |
| 136,000 | |
| 11,938,000 | |
| 12,012,000 | |
| 12,011,000 | |
| 12,009,000 | |
| 169,000 | |
| 83,000 | |
| 48,000 | |
| 48,000 | |
| 75,000 | |
| 75,000 | |
| -933,838 | |
| 89,162 | |
| 65,796 | |
| 65,796 | |
| -23,911,785 |